Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register account icon
S&P 500
7,599.96
(
0.26%
)
US TECH 100
29,611.20
(
0.27%
)
Dow Jones
51,078.88
(
0.09%
)
Brent Oil
93.61
(
-2.46%
)
Bitcoin
70,242.00
(
-1.58%
)
News Focus
News Focus
Post# of 48316
Next 10
Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next

lasers

Send PM Follow Ignore
Followers 590
Posts 20577
Boards Moderated 0
Alias Born 02/01/2012

lasers

Re: twiz0019 post# 40311

Thursday, 10/19/2017 6:57:32 AM

Thursday, October 19, 2017 6:57:32 AM

Post# of 48316
$ONCS results is everything we had hoped for and more!. BORR 50%

OncoSec Presents Positive Phase 2 Data for ImmunoPulse® IL-12 in Combination with Pembrolizumab Demonstrating a Best Overall Response Rate (BORR) of 50% in Predicted Anti-PD-1 Non-Responder Melanoma PatientsData from Recently Completed Phase 2 Monotherapy and Combination Therapy Studies

Public Reply Private Reply New Post
Keep Last Read
Replies (2) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (2) Next 10 Prev Next
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Detailed Quote